Of dogs, their tails and cowardice, Sector. You've snapped your fangs a dozen times (completely unprompted AGAIN in your latest snap at me) at all and sundry above and now declare yourself stalked. Diddums. Poor sore troll.
You spend all day hurling insults on here. Perhaps a way to vent your anger at your losses on the value of your self declared 'massive' position in CYP. If it drops too low I will help stem the falls and your anger with a little clip here and there
. A bargain at these prices I will happily buy at, but I like value and biding my time and unlike you pay very little for my brokerage costs, so I can afford to pick at it, and you won't find me on the individual shareholder register either by the way
. Perhaps I am now in one of those nominee account holdings creeping up the share registry, now the stock is at very tempting levels.
For other suffering shareholders,
I wouldn't be surprised if even Sumitomo are tempted to swallow their pride at these levels. CYP a bargain down here with all its trials in play. Its a very cheap call option for them or other big Pharma on a fully funded phase III trial.
They and you know the overall costs of the Sculptor phase III trials alone - which CYP has to put no cash towards - are probably larger than CYP's mkt cap right now - and $18 mill on the books to boot! This company would be a bargain purchase.
(20min delay)